thymopentin has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YF; Dai, KY; Ji, HY; Liu, AJ; Liu, C; Yu, J | 1 |
| Li, T; Li, ZW; Wen, HC | 1 |
| Ameglio, F; Di Lauro, L; Gandolfo, G; Gionfra, T; Lopez, M; Paoletti, G | 1 |
2 trial(s) available for thymopentin and Liver Neoplasms
| Article | Year |
|---|---|
[Study on the efficacy and safety of high dose thymopentin combined with trans-artery chemoembolization for primary liver cancer].
Topics: Adjuvants, Immunologic; Adult; Aged; Asthenia; CD4-Positive T-Lymphocytes; Chemoembolization, Therapeutic; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Fever; Fluorouracil; Humans; Iodized Oil; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Survival Rate; Thymopentin | 2007 |
Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: preliminary results.
Topics: Adenocarcinoma; Colorectal Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Interleukin-2; Leucovorin; Liver Neoplasms; Male; Middle Aged; Thymopentin | 1991 |
1 other study(ies) available for thymopentin and Liver Neoplasms
| Article | Year |
|---|---|
The immunosuppressive effects of low molecular weight chitosan on thymopentin-activated mice bearing H22 solid tumors.
Topics: Animals; Blood Cell Count; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Chitosan; Cytokines; Female; Liver Neoplasms; Mice; Mice, Inbred BALB C; Molecular Weight; T-Lymphocytes; Thymopentin | 2021 |